Differential Recognition of P. falciparum VAR2CSA Domains by Naturally Acquired Antibodies in Pregnant Women from a Malaria Endemic Area
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index; 1 of the 10 sources its claims cite were checked for support.
Abstract
Study showing differential recognition of VAR2CSA domains by naturally acquired antibodies in pregnant women in a malaria endemic area, with parity-related patterns.
Overview
CoChat Summary
TL;DR
This study found that antibodies to the VAR2CSA DBL5ε domain in pregnant Malawian women increased with parity and correlated with antibodies to placental parasite surface antigens, supporting DBL5ε as a vaccine candidate for pregnancy-associated malaria. HIV co-infection was associated with lower anti-DBL5ε IgG levels, and in primigravidae it was also associated with lower antibody affinity to DBL5ε.
Key findings
- In 189 primigravidae, 21 secundigravidae, and 72 multigravidae, multigravid women had significantly higher levels of VSA-PAM antibodies than primigravid women (Kruskal-Wallis ANOVA, p = 0.0001; Dunn’s test, p<0.001).
- DBL5ε showed the clearest parity-dependent recognition: multigravid women had higher anti-DBL5ε antibodies than primigravidae (Kruskal-Wallis ANOVA, p = 0.0141; Dunn’s test, p<0.05), and anti-DBL5ε levels correlated with VSA-PAM antibodies (Spearman r = 0.5632, p<0.0001).
- HIV-positive women had lower anti-DBL5ε IgG than HIV-negative women of similar parity; this difference was significant in multigravidae (p = 0.023). In primigravidae, HIV-positive women also had lower affinity to DBL5ε, with higher dissociation rate constant kd (t-test, p = 0.0230).
- Anti-DBL5ε levels and total VSA-PAM antibodies correlated with parasitemia in some groups, including VSA-PAM vs parasitemia overall (Spearman r = 0.2134, p = 0.0005) and DBL5ε vs parasitemia in primigravidae (r = 0.2000, p = 0.0123).
Methods
- Pregnant women attending Queen Elizabeth Central Hospital in Blantyre, Malawi were enrolled in late third trimester; serum samples were analyzed from 189 primigravidae, 21 secundigravidae, and 72 multigravidae.
- Flow cytometry on CS2 infected red blood cells measured antibodies to VSA-PAM, and CHO-745 cells expressing VAR2CSA DBL domains were used to quantify domain-specific IgG.
- Surface plasmon resonance on recombinant FCR3 VAR2CSA DBL5ε measured dissociation rate constants (kd) as an indicator of antibody affinity; statistical tests included Kruskal-Wallis ANOVA with Dunn’s post hoc tests, Spearman correlations, and t-tests.
Limitations
- The paper explicitly notes that only a “convenience selection” of stored serum samples was used, which limits representativeness.
- The text makes evident that sample sizes were uneven across parity groups, especially the small secundigravidae group (21), which may reduce power for subgroup comparisons.
- The paper does not report the results of some assays in full in the provided text, so some detailed outcomes are not stated in the paper excerpt.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
1 Valid · 0 Not valid · 9 Not checked · 25 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Levels of anti-DBL5ε IgG have also been positively associated with birth weight, again indicating their protective effect [6].”
§ Differential Recognition of P. falciparum VAR2CSA Domains by Naturally Acquired Antibodies in Pregnant Women from a Malaria Endemic Area > Discussion In this study investigating VAR2CSA DBL-domain specific immune response, we show the VAR2CSA domains DBL5ε and DBL6ε to be recognized in a gender specific manner (figure 1B). DBL5ε also displays a parity dependent recognition, as previously described for VSA-PAM antibodies [34], [35] suggesting this domain to be important in a protective response against PAM (figure 1E). All DBL-domains contain both conserved and polymorphic regions targeted by surface reactive antibodies, but the conserved regions are most prominent in DBL3x and DBL5ε [36]. Further, DBL5ε is highly conserved between both laboratory and clinical isolates, and most sequence differences localize to flexible loops in the protein [37], [38]. A recent study indicates that antibodies raised against DBL3x and DBL5ε domains are highly cross-reactive with several placental isolates [39]. We demonstrate a correlation between antibodies against a VAR2CSA expressing parasite line and DBL5ε domain specific antibodies, suggesting this domain to be a prominent target of antibodies developed in malaria infection during pregnancy. A study by Oleinikov et al showed that most antibodies elicited following immunization with DBL5ε and DBL6ε recognize polymorphic epitopes in the native protein [40]. Levels of adhesion-inhibitory antibody correlated with levels of anti-DBL5ε antibodies [41], and a recent study illustrated how antibodies raised against DBL3x and DBL5ε were highly cross-reactive with heterologous parasites [42]. Furthermore, in this study we used DBL5ε from three different parasite isolates (CS2, to measure total VSA-PAM antibody levels; 3D7 domains expressed in CHO cells; and FCR3 in affinity studies) with results correlating significantly (figure 4A and B). Also, the rMFI for antibodies against VSA-PAM and antibodies against DBL5ε have a very strong resemblance to each other across the population (figure 4A and B). Levels of anti-DBL5ε IgG have also been positively associated with birth weight, again indicating their protective effect [6]. A VAR2CSA vaccine will need to elicit a cross-reactive antibody response in order to be widely effective, and our data in conjunction with earlier studies [36], [41], [43] indicate DBL5ε to be a promising vaccine candidate. In order to succeed in blocking iRBC adhesion to CSA in the placenta of pregnant women, it is possible that antibodies need not only to bind, but also to do so at strong affinity. Using the surface plasmon resonance technique, we found that even though multigravid women have slightly higher levels of antibodies against DBL5ε than primigravidae, there was no significant difference in the dissociation rate constant of antibodies against this VAR2CSA domain between the groups. Diving deeper into the different parities and the effect of HIV co-infection, antibodies against DBL5ε in primigravid HIV positive women tested had lower affinity than sera from HIV negative primigravidae from the same region (figure 3B), suggesting HIV infection to impair the strength of antibody binding. Among multigravid HIV, levels of DBL5ε antibodies were lower in HIV positive women (figure 2) but affinity was similar to that of antibodies present in HIV negative women (figure 3C). However, levels of total VSA-PAM antibodies as well as anti-DBL5ε antibodies correlate significantly with the dissociation rate constant used as an indicator of affinity of these antibodies (figure 4A and B). Since HIV in multigravid women seems to impair a pregnant woman's ability to control parasitemia, levels of antibodies are an important determinant of favorable birth outcomes and as a sign for less disease in these women [28]. Our data indicate that HIV infection impairs antibody affinity in primigravidae more than in multigravidae. One hypothesis would argue that antibody affinity is important in primigravidae when antibody levels are low whereas antibody levels and functionalities such as facilitation of opsonic activity may be more important determinants of outcome in multigravid women. Phagocytic activity of cytophilic antibodies is known to be impaired in multigravidae infected with HIV whereas no difference is seen in HIV infected and HIV uninfected primigravid women [23], [24]. Many studies have investigated presence, levels and function of antibodies targeting VSA-PAM, but less is known concerning the dynamics of binding interactions. It could be so that antibodies, to be protective, need to bind with high affinity. Some studies found no association between high levels of VSA-PAM antibodies and adhesion inhibition [44], whereas some clearly show this correlation [34]. We hypothesize that high affinity antibodies are protective whereas low affinity antibodies are less so and thereby rely more on increased levels and various antibody functions independent of the antibody binding equilibrium such as phagocytic activity and ability to block placental adhesion.
What the sources say
- Supportedcites [6] A Salanti, 2004, Evidence for the involvement of VAR2CSA in pregnancy-associated malaria., Journal of Experimental Medicine source
The Results and Discussion report that, among women with active-chronic pregnancy-associated malaria, those with high VAR2CSA DBL5-ɛ–specific IgG had heavier babies and a lower risk of a seriously underweight infant. The conclusion links high VAR2CSA-specific IgG to favorable birth outcomes and suggests a possible protective role, consistent with the citing sentence’s wording. (LLM, conf=0.91)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Also, the rMFI for antibodies against VSA-PAM and antibodies against DBL5ε have a very strong resemblance to each other across the population (figure 4A and B).”
§ Differential Recognition of P. falciparum VAR2CSA Domains by Naturally Acquired Antibodies in Pregnant Women from a Malaria Endemic Area > Discussion In this study investigating VAR2CSA DBL-domain specific immune response, we show the VAR2CSA domains DBL5ε and DBL6ε to be recognized in a gender specific manner (figure 1B). DBL5ε also displays a parity dependent recognition, as previously described for VSA-PAM antibodies [34], [35] suggesting this domain to be important in a protective response against PAM (figure 1E). All DBL-domains contain both conserved and polymorphic regions targeted by surface reactive antibodies, but the conserved regions are most prominent in DBL3x and DBL5ε [36]. Further, DBL5ε is highly conserved between both laboratory and clinical isolates, and most sequence differences localize to flexible loops in the protein [37], [38]. A recent study indicates that antibodies raised against DBL3x and DBL5ε domains are highly cross-reactive with several placental isolates [39]. We demonstrate a correlation between antibodies against a VAR2CSA expressing parasite line and DBL5ε domain specific antibodies, suggesting this domain to be a prominent target of antibodies developed in malaria infection during pregnancy. A study by Oleinikov et al showed that most antibodies elicited following immunization with DBL5ε and DBL6ε recognize polymorphic epitopes in the native protein [40]. Levels of adhesion-inhibitory antibody correlated with levels of anti-DBL5ε antibodies [41], and a recent study illustrated how antibodies raised against DBL3x and DBL5ε were highly cross-reactive with heterologous parasites [42]. Furthermore, in this study we used DBL5ε from three different parasite isolates (CS2, to measure total VSA-PAM antibody levels; 3D7 domains expressed in CHO cells; and FCR3 in affinity studies) with results correlating significantly (figure 4A and B). Also, the rMFI for antibodies against VSA-PAM and antibodies against DBL5ε have a very strong resemblance to each other across the population (figure 4A and B). Levels of anti-DBL5ε IgG have also been positively associated with birth weight, again indicating their protective effect [6]. A VAR2CSA vaccine will need to elicit a cross-reactive antibody response in order to be widely effective, and our data in conjunction with earlier studies [36], [41], [43] indicate DBL5ε to be a promising vaccine candidate. In order to succeed in blocking iRBC adhesion to CSA in the placenta of pregnant women, it is possible that antibodies need not only to bind, but also to do so at strong affinity. Using the surface plasmon resonance technique, we found that even though multigravid women have slightly higher levels of antibodies against DBL5ε than primigravidae, there was no significant difference in the dissociation rate constant of antibodies against this VAR2CSA domain between the groups. Diving deeper into the different parities and the effect of HIV co-infection, antibodies against DBL5ε in primigravid HIV positive women tested had lower affinity than sera from HIV negative primigravidae from the same region (figure 3B), suggesting HIV infection to impair the strength of antibody binding. Among multigravid HIV, levels of DBL5ε antibodies were lower in HIV positive women (figure 2) but affinity was similar to that of antibodies present in HIV negative women (figure 3C). However, levels of total VSA-PAM antibodies as well as anti-DBL5ε antibodies correlate significantly with the dissociation rate constant used as an indicator of affinity of these antibodies (figure 4A and B). Since HIV in multigravid women seems to impair a pregnant woman's ability to control parasitemia, levels of antibodies are an important determinant of favorable birth outcomes and as a sign for less disease in these women [28]. Our data indicate that HIV infection impairs antibody affinity in primigravidae more than in multigravidae. One hypothesis would argue that antibody affinity is important in primigravidae when antibody levels are low whereas antibody levels and functionalities such as facilitation of opsonic activity may be more important determinants of outcome in multigravid women. Phagocytic activity of cytophilic antibodies is known to be impaired in multigravidae infected with HIV whereas no difference is seen in HIV infected and HIV uninfected primigravid women [23], [24]. Many studies have investigated presence, levels and function of antibodies targeting VSA-PAM, but less is known concerning the dynamics of binding interactions. It could be so that antibodies, to be protective, need to bind with high affinity. Some studies found no association between high levels of VSA-PAM antibodies and adhesion inhibition [44], whereas some clearly show this correlation [34]. We hypothesize that high affinity antibodies are protective whereas low affinity antibodies are less so and thereby rely more on increased levels and various antibody functions independent of the antibody binding equilibrium such as phagocytic activity and ability to block placental adhesion.
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Levels of VSA-PAM antibodies and DBL5ε specific antibodies showed a significant positive moderate correlation (Spearman r = 0.5632, p<0.0001), suggesting that DBL5ε may be important in the acquired immune response against PAM (figure 1F).”
§ Differential Recognition of P. falciparum VAR2CSA Domains by Naturally Acquired Antibodies in Pregnant Women from a Malaria Endemic Area > Results > VAR2CSA DBL-Domains Are Recognized by Immune Sera from Pregnant Adults We used flow cytometry to measure antibody levels in a panel of sera from Malawian pregnant women to the variant surface antigens (VSA) of P. falciparum VAR2CSA expressing lab isolate CS2 [32] (figure 1A and figure S1). This analysis showed multigravid (MG) women to have significantly higher levels of VSA-PAM antibodies than primigravid (PG) women from the same endemic area (Kruskal-Wallis ANOVA, p = 0.0001 followed by Dunn's Multiple Comparison test, p<0.001). We then used CHO-745 cells transfected with 3D7 VAR2CSA DBLdomains, described elsewhere [14], to investigate the domain specificity of these acquired antibodies (figure S2 and S3). Previous studies showed the various domains to be expressed on the surface of the transfected CHO-745 cells at similar magnitudes [19], and the level of surface expression was also monitored for each experiment in this study (figure S3). Using the panel of sera from Malawian pregnant women described above, we assayed levels of DBL domain specific antibodies. Flow cytometry assays using these VAR2CSA DBL domain transfected cells showed various patterns. After initial screening of all six DBL domains using serum samples from Malawian women with different parities (data not shown), additional serum samples were tested using domains DBL3x, DBL5ε and DBL6ε (Figure 1B). The reason for choosing these domains is the distinctly higher recognition of these domains by pooled hyperimmune multigravid sera than pooled male immune sera from individuals living in the same area, demonstrating a gender specific antibody recognition pattern of these three domains. The pattern of DBL3x recognition indicated that antibodies in sera from primigravidae show similar recognition of this domain to those in sera from multigravidae (Kruskal-Wallis ANOVA, p = 0.0589, figure 1C). Neither did antibody levels to DBL3x correlate with antibody levels to VSA-PAM antibodies (Spearman r = −0.08980, p = 0.3972, figure 1D). Notably, A4 DBL3x transfected CHO-745 cells were used as a complement to 3D7 DBL3x transfected CHO-745 cells since the 3D7 variant was shown to contain a 12-mer residue deletion and did not bind CSA [33]. From this further analysis, it is apparent that DBL5ε was the only domain to induce a clear parity dependent recognition pattern, with multigravid women boasting notably higher levels of anti-DBL5ε antibodies than primigravidae (Kruskall-Wallis ANOVA, p = 0.0141; Dunn's Multiple Comparison test, p<0.05 (PG versus MG), figure 1E). Levels of VSA-PAM antibodies and DBL5ε specific antibodies showed a significant positive moderate correlation (Spearman r = 0.5632, p<0.0001), suggesting that DBL5ε may be important in the acquired immune response against PAM (figure 1F). The pattern of VAR2CSA DBL6ε antibody recognition indicates this domain to also be recognized by multigravid women to a similar extent as primigravidae (Kruskall-Wallis ANOVA, p = 0.5118, figure 1G). Levels of antibodies against DBL6ε did show a significant positive weak correlation with levels of antibodies against VSA-PAM (Spearman r = 0.2905, p = 0.0013, figure 1H). Analyzing the effect of HIV infection on antibody levels to DBL5ε revealed HIV negative women to have higher antibody levels than HIV positive women in all parity groups, but the difference was only significant in multigravidae (Kruskall-Wallis ANOVA, p = 0.023, Dunn's Multiple Comparison test, p<0.05 (PG versus MG), figure 2). We also investigated the possible correlation between parasitemia (parasites per µl) at the time of serum collection and antibody levels against VSA-PAM as well as against DBL5ε (figure S4). We found a weak significant correlation (Spearman r = 0.2134, p = 0.0005) between antibodies against VSA-PAM and parasitemia, something that holds true also for primigravidae (Spearman r = 0.2819, p = 0.0002) and multigravidae (Spearman r = 0.2833, p = 0.0175), but not for secundigravide. We also found a weak significant correlation (Spearman r = 0.2000, p = 0.0123) between antibodies against VAR2CSA DBL5ε and parasitemia in primigraviade but nor for secundi- or multigravidae nor for these three groups together.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither did antibody levels to DBL3x correlate with antibody levels to VSA-PAM antibodies (Spearman r = −0.08980, p = 0.3972, figure 1D).”
§ Differential Recognition of P. falciparum VAR2CSA Domains by Naturally Acquired Antibodies in Pregnant Women from a Malaria Endemic Area > Results > VAR2CSA DBL-Domains Are Recognized by Immune Sera from Pregnant Adults We used flow cytometry to measure antibody levels in a panel of sera from Malawian pregnant women to the variant surface antigens (VSA) of P. falciparum VAR2CSA expressing lab isolate CS2 [32] (figure 1A and figure S1). This analysis showed multigravid (MG) women to have significantly higher levels of VSA-PAM antibodies than primigravid (PG) women from the same endemic area (Kruskal-Wallis ANOVA, p = 0.0001 followed by Dunn's Multiple Comparison test, p<0.001). We then used CHO-745 cells transfected with 3D7 VAR2CSA DBLdomains, described elsewhere [14], to investigate the domain specificity of these acquired antibodies (figure S2 and S3). Previous studies showed the various domains to be expressed on the surface of the transfected CHO-745 cells at similar magnitudes [19], and the level of surface expression was also monitored for each experiment in this study (figure S3). Using the panel of sera from Malawian pregnant women described above, we assayed levels of DBL domain specific antibodies. Flow cytometry assays using these VAR2CSA DBL domain transfected cells showed various patterns. After initial screening of all six DBL domains using serum samples from Malawian women with different parities (data not shown), additional serum samples were tested using domains DBL3x, DBL5ε and DBL6ε (Figure 1B). The reason for choosing these domains is the distinctly higher recognition of these domains by pooled hyperimmune multigravid sera than pooled male immune sera from individuals living in the same area, demonstrating a gender specific antibody recognition pattern of these three domains. The pattern of DBL3x recognition indicated that antibodies in sera from primigravidae show similar recognition of this domain to those in sera from multigravidae (Kruskal-Wallis ANOVA, p = 0.0589, figure 1C). Neither did antibody levels to DBL3x correlate with antibody levels to VSA-PAM antibodies (Spearman r = −0.08980, p = 0.3972, figure 1D). Notably, A4 DBL3x transfected CHO-745 cells were used as a complement to 3D7 DBL3x transfected CHO-745 cells since the 3D7 variant was shown to contain a 12-mer residue deletion and did not bind CSA [33]. From this further analysis, it is apparent that DBL5ε was the only domain to induce a clear parity dependent recognition pattern, with multigravid women boasting notably higher levels of anti-DBL5ε antibodies than primigravidae (Kruskall-Wallis ANOVA, p = 0.0141; Dunn's Multiple Comparison test, p<0.05 (PG versus MG), figure 1E). Levels of VSA-PAM antibodies and DBL5ε specific antibodies showed a significant positive moderate correlation (Spearman r = 0.5632, p<0.0001), suggesting that DBL5ε may be important in the acquired immune response against PAM (figure 1F). The pattern of VAR2CSA DBL6ε antibody recognition indicates this domain to also be recognized by multigravid women to a similar extent as primigravidae (Kruskall-Wallis ANOVA, p = 0.5118, figure 1G). Levels of antibodies against DBL6ε did show a significant positive weak correlation with levels of antibodies against VSA-PAM (Spearman r = 0.2905, p = 0.0013, figure 1H). Analyzing the effect of HIV infection on antibody levels to DBL5ε revealed HIV negative women to have higher antibody levels than HIV positive women in all parity groups, but the difference was only significant in multigravidae (Kruskall-Wallis ANOVA, p = 0.023, Dunn's Multiple Comparison test, p<0.05 (PG versus MG), figure 2). We also investigated the possible correlation between parasitemia (parasites per µl) at the time of serum collection and antibody levels against VSA-PAM as well as against DBL5ε (figure S4). We found a weak significant correlation (Spearman r = 0.2134, p = 0.0005) between antibodies against VSA-PAM and parasitemia, something that holds true also for primigravidae (Spearman r = 0.2819, p = 0.0002) and multigravidae (Spearman r = 0.2833, p = 0.0175), but not for secundigravide. We also found a weak significant correlation (Spearman r = 0.2000, p = 0.0123) between antibodies against VAR2CSA DBL5ε and parasitemia in primigraviade but nor for secundi- or multigravidae nor for these three groups together.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“something that holds true also for primigravidae (Spearman r = 0.2819, p = 0.0002)”
§ Differential Recognition of P. falciparum VAR2CSA Domains by Naturally Acquired Antibodies in Pregnant Women from a Malaria Endemic Area > Results > VAR2CSA DBL-Domains Are Recognized by Immune Sera from Pregnant Adults We used flow cytometry to measure antibody levels in a panel of sera from Malawian pregnant women to the variant surface antigens (VSA) of P. falciparum VAR2CSA expressing lab isolate CS2 [32] (figure 1A and figure S1). This analysis showed multigravid (MG) women to have significantly higher levels of VSA-PAM antibodies than primigravid (PG) women from the same endemic area (Kruskal-Wallis ANOVA, p = 0.0001 followed by Dunn's Multiple Comparison test, p<0.001). We then used CHO-745 cells transfected with 3D7 VAR2CSA DBLdomains, described elsewhere [14], to investigate the domain specificity of these acquired antibodies (figure S2 and S3). Previous studies showed the various domains to be expressed on the surface of the transfected CHO-745 cells at similar magnitudes [19], and the level of surface expression was also monitored for each experiment in this study (figure S3). Using the panel of sera from Malawian pregnant women described above, we assayed levels of DBL domain specific antibodies. Flow cytometry assays using these VAR2CSA DBL domain transfected cells showed various patterns. After initial screening of all six DBL domains using serum samples from Malawian women with different parities (data not shown), additional serum samples were tested using domains DBL3x, DBL5ε and DBL6ε (Figure 1B). The reason for choosing these domains is the distinctly higher recognition of these domains by pooled hyperimmune multigravid sera than pooled male immune sera from individuals living in the same area, demonstrating a gender specific antibody recognition pattern of these three domains. The pattern of DBL3x recognition indicated that antibodies in sera from primigravidae show similar recognition of this domain to those in sera from multigravidae (Kruskal-Wallis ANOVA, p = 0.0589, figure 1C). Neither did antibody levels to DBL3x correlate with antibody levels to VSA-PAM antibodies (Spearman r = −0.08980, p = 0.3972, figure 1D). Notably, A4 DBL3x transfected CHO-745 cells were used as a complement to 3D7 DBL3x transfected CHO-745 cells since the 3D7 variant was shown to contain a 12-mer residue deletion and did not bind CSA [33]. From this further analysis, it is apparent that DBL5ε was the only domain to induce a clear parity dependent recognition pattern, with multigravid women boasting notably higher levels of anti-DBL5ε antibodies than primigravidae (Kruskall-Wallis ANOVA, p = 0.0141; Dunn's Multiple Comparison test, p<0.05 (PG versus MG), figure 1E). Levels of VSA-PAM antibodies and DBL5ε specific antibodies showed a significant positive moderate correlation (Spearman r = 0.5632, p<0.0001), suggesting that DBL5ε may be important in the acquired immune response against PAM (figure 1F). The pattern of VAR2CSA DBL6ε antibody recognition indicates this domain to also be recognized by multigravid women to a similar extent as primigravidae (Kruskall-Wallis ANOVA, p = 0.5118, figure 1G). Levels of antibodies against DBL6ε did show a significant positive weak correlation with levels of antibodies against VSA-PAM (Spearman r = 0.2905, p = 0.0013, figure 1H). Analyzing the effect of HIV infection on antibody levels to DBL5ε revealed HIV negative women to have higher antibody levels than HIV positive women in all parity groups, but the difference was only significant in multigravidae (Kruskall-Wallis ANOVA, p = 0.023, Dunn's Multiple Comparison test, p<0.05 (PG versus MG), figure 2). We also investigated the possible correlation between parasitemia (parasites per µl) at the time of serum collection and antibody levels against VSA-PAM as well as against DBL5ε (figure S4). We found a weak significant correlation (Spearman r = 0.2134, p = 0.0005) between antibodies against VSA-PAM and parasitemia, something that holds true also for primigravidae (Spearman r = 0.2819, p = 0.0002) and multigravidae (Spearman r = 0.2833, p = 0.0175), but not for secundigravide. We also found a weak significant correlation (Spearman r = 0.2000, p = 0.0123) between antibodies against VAR2CSA DBL5ε and parasitemia in primigraviade but nor for secundi- or multigravidae nor for these three groups together.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
18 more claims
Create a free account to see all 35 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 3
Citations
Cites
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Fried, M., & Duffy, P. E. (1996) · Science · doi:10.1126/science.272.5267.1502 · Cited by 1,108 · cited 1×
“IRBC expressing the adhesin VAR2CSA adhere to the receptor CSA expressed by syncytiotrophoblast [4,5,6,7], and potentially enable the parasites to evade the immune system and successfully proliferate.”
BackgroundThe burden of malaria in pregnancy in malaria-endemic areas
Steketee, R., Nahlen, B., Parise, M., & Menendez, C. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.28 · Cited by 1,063 · cited 1×
“falciparum malaria, pregnant women are highly susceptible to PAM [8], leading to maternal anemia, low birth weight, miscarriage and stillbirths [9,10,11].”
BackgroundAn analysis of malaria in pregnancy in Africa.
Brabin, B. J. (1983) · PubMed Central · Cited by 877
Maternal antibodies block malaria
Fried, M., Nosten, F., Brockman, A., Brabin, B. J., & Duffy, P. E. (1998) · Nature · doi:10.1038/27570 · Cited by 659 · cited 1×
“adhesion to placental receptors [21] and to facilitate opsonic uptake by phagocytes [22,23,24].”
BackgroundEvidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041579 · Cited by 604 · cited 1×
“DBL5e also displays a parity dependent recognition, as previously described for VSA-PAM antibodies [34,35] suggesting this domain to be important in a protective response against PAM (figure 1E).”
BackgroundImpact of malaria during pregnancy on low birth weight in sub-Saharan Africa
Guyatt, H. L., & Snow, R. W. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.760-769.2004 · Cited by 458 · cited 1×
“falciparum malaria, pregnant women are highly susceptible to PAM [8], leading to maternal anemia, low birth weight, miscarriage and stillbirths [9,10,11].”
BackgroundParise, M. E., Ayisi, J. G., Nahlen, B. L., Schultz, L. J., Roberts, J. M., Misore, A., Muga, R., Oloo, A. J., & Steketee, R. W. (1998) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.1998.59.813 · Cited by 388 · cited 1×
“In several studies, it has been shown that HIV positive women receiving intermittent preventive treatment in pregnancy (IPTp) need additional doses of drugs in order to be protected [28,29,30], further reflecting the need for increased knowledge of antibody dynamics.”
BackgroundThe Sick Placenta—The Role of Malaria
Brabin, B. J., Romagosa, C., Abdelgalil, S., Menéndez, C., Verhoeff, F. H., McGready, R., Fletcher, K. A., Owens, S., d'Alessandro, U., Nosten, F., et al. (2004) · Placenta · doi:10.1016/j.placenta.2003.10.019 · Cited by 375 · cited 1×
“Pregnancy-associated malaria (PAM) has a major impact on the mother and child [1] and is often associated with the sequestration of Plasmodium falciparum infected red blood cells (iRBC) in the placenta [2,3].”
BackgroundTER KUILE, F. O., PARISE, M. E., VERHOEFF, F. H., UDHAYAKUMAR, V., NEWMAN, R. D., VAN EIJK, A. M., ROGERSON, S. J., & STEKETEE, R. W. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.41 · Cited by 364
Self-citationChondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes.
Rogerson, S. J., Chaiyaroj, S. C., Ng, K., Reeder, J. C., & Brown, G. V. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.15 · Cited by 342 · cited 1×
“IRBC expressing the adhesin VAR2CSA adhere to the receptor CSA expressed by syncytiotrophoblast [4,5,6,7], and potentially enable the parasites to evade the immune system and successfully proliferate.”
BackgroundSelf-citationTolia, N. H., Enemark, E. J., Sim, B. K. L., & Joshua-Tor, L. (2005) · Cell · doi:10.1016/j.cell.2005.05.033 · Cited by 330 · cited 1×
“. Further, DBL5e is highly conserved between both laboratory and clinical isolates, and most sequence differences localize to flexible loops in the protein”
Ricke, C. H., Staalsoe, T., Koram, K., Akanmori, B. D., Riley, E. M., Theander, T. G., & Hviid, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3309 · Cited by 303 · cited 1×
“DBL5e also displays a parity dependent recognition, as previously described for VSA-PAM antibodies [34,35] suggesting this domain to be important in a protective response against PAM (figure 1E).”
BackgroundPlacental pathologic changes in malaria. A histologic and ultrastructural study.
Walter, P. R., GARIN, Y. J. F., & Blot, P. (1982) · PubMed Central · Cited by 286
Smith, J. D., Subramanian, G., Gamain, B., Baruch, D. I., & Miller, L. H. (2000) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(00)00279-6 · Cited by 276 · cited 1×
“VAR2CSA is a member of the PfEMP1 family but displays a different domain architecture than typical PfEMP1s and has an unusual high sequence conservation between isolates [12,13].”
BackgroundSteketee, R. W., Chilima, B., Chitsulo, L., Bloland, P. B., Breman, J. G., Mermin, J. H., & Wirima, J. J. (1996) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.55.42 · Cited by 260 · cited 3×
“HIV positive women in their first pregnancy do not experience a significantly increased risk of malaria prevalence, but do retain significantly higher parasite density [28].”
BackgroundGuyatt, H., & Snow, R. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.36 · Cited by 252 · cited 1×
“falciparum malaria, pregnant women are highly susceptible to PAM [8], leading to maternal anemia, low birth weight, miscarriage and stillbirths [9,10,11].”
BackgroundStructural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain
Singh, S. K., Hora, R., Belrhali, H., Chitnis, C. E., & Sharma, A. (2006) · Nature · doi:10.1038/nature04443 · Cited by 247
Viebig, N. K., Gamain, B., Scheidig, C., Lépolard, C., Przyborski, J., Lanzer, M., Gysin, J., & Scherf, A. (2005) · The EMBO Reports · doi:10.1038/sj.embor.7400466 · Cited by 201 · cited 1×
“IRBC expressing the adhesin VAR2CSA adhere to the receptor CSA expressed by syncytiotrophoblast [4,5,6,7], and potentially enable the parasites to evade the immune system and successfully proliferate.”
BackgroundTrimnell, A. R., Kraemer, S. M., Mukherjee, S., Phippard, D. J., Janes, J. H., Flamoe, E., Su, X.-Z., Awadalla, P., & Smith, J. D. (2006) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2006.03.012 · Cited by 165 · cited 1×
“VAR2CSA is a member of the PfEMP1 family but displays a different domain architecture than typical PfEMP1s and has an unusual high sequence conservation between isolates [12,13].”
BackgroundRole of Nonimmune IgG Bound to PfEMP1 in Placental Malaria
Flick, K., Scholander, C., Chen, Q., Fernandez, V., Pouvelle, B., Gysin, J., & Wahlgren, M. (2001) · Science · doi:10.1126/science.1062891 · Cited by 152 · cited 3×
“Malaria naı̈ve sera showed binding only at background levels and as an extra control, we also used non-immune IgG and PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e9230 IgM as well as IgG depleted non-immune sera, neither exhibiting binding using the surface plasmon resonance technique (data not s…”
BackgroundSelf-citationGamain, B., Trimnell, A. R., Scheidig, C., Scherf, A., Miller, L. H., & Smith, J. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/428137 · Cited by 145 · cited 3×
“AAQ73926) were amplified from genomic DNA by PCR and cloned into the pSRa5-12CA5 vector (Affymax Research Institute, Palo Alto, CA) as described [14].”
BackgroundMethodImpairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection.
Mount, A. M., Mwapasa, V., Elliott, S. R., Beeson, J. G., Tadesse, E., Lema, V. M., Molyneux, M. E., Meshnick, S. R., & Rogerson, S. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16354-x · Cited by 144 · cited 2×
“Pregnant women attending the Queen Elizabeth Central Hospital, Blantyre, Malawi in late third trimester of pregnancy were enrolled into a study of interactions between HIV and malaria in pregnancy, as described elsewhere [26,31].”
BackgroundMethodSelf-citationMwapasa, V., Rogerson, S. J., Molyneux, M. E., Abrams, E. T., Kamwendo, D. D., Lema, V. M., Tadesse, E., Chaluluka, E., Wilson, P. E., & Meshnick, S. R. (2004) · AIDS · doi:10.1097/00002030-200404300-00014 · Cited by 142 · cited 1×
“Pregnant women attending the Queen Elizabeth Central Hospital, Blantyre, Malawi in late third trimester of pregnancy were enrolled into a study of interactions between HIV and malaria in pregnancy, as described elsewhere [26,31].”
MethodSelf-citationHIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya
van Eijk, A. M., Ayisi, J. G., Ter Kuile, F. O., Misore, A. O., Otieno, J. A., Rosen, D. H., Kager, P. A., Steketee, R. W., & Nahlen, B. L. (2003) · AIDS · doi:10.1097/00002030-200303070-00015 · Cited by 128
Barfod, L., Bernasconi, N. L., Dahlbäck, M., Jarrossay, D., Andersen, P. H., Salanti, A., Ofori, M. F., Turner, L., Resende, M., Nielsen, M. A., et al. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05503.x · Cited by 110 · cited 4×
“All DBL-domains contain both conserved and polymorphic regions targeted by surface reactive antibodies, but the conserved regions are most prominent in DBL3x and DBL5e [36].”
BackgroundInfluentialFiller, S. J., Kazembe, P., Thigpen, M., Macheso, A., Parise, M. E., Newman, R. D., Steketee, R. W., & Hamel, M. (2006) · The Journal of Infectious Diseases · doi:10.1086/505080 · Cited by 108 · cited 1×
“In several studies, it has been shown that HIV positive women receiving intermittent preventive treatment in pregnancy (IPTp) need additional doses of drugs in order to be protected [28,29,30], further reflecting the need for increased knowledge of antibody dynamics.”
BackgroundDuffy, M. F., Byrne, T. J., Elliott, S. R., Wilson, D. W., Rogerson, S. J., Beeson, J. G., Noviyanti, R., & Brown, G. V. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04577.x · Cited by 93 · cited 5×
“VAR2CSA DBL-Domains Are Recognized by Immune Sera from Pregnant Adults We used flow cytometry to measure antibody levels in a panel of sera from Malawian pregnant women to the variant surface antigens (VSA) of P. falciparum VAR2CSA expressing lab isolate CS2 [32] (figure 1A and figure S1).”
BackgroundSelf-citationHIV Impairs Opsonic Phagocytic Clearance of Pregnancy-Associated Malaria Parasites
Keen, J., Serghides, L., Ayi, K., Patel, S. N., Ayisi, J., van Eijk, A., Steketee, R., Udhayakumar, V., & Kain, K. C. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040181 · Cited by 92 · cited 2×
“adhesion to placental receptors [21] and to facilitate opsonic uptake by phagocytes [22,23,24].”
BackgroundDynamics of Anti‐VAR2CSA Immunoglobulin G Response in a Cohort of Senegalese Pregnant Women
Tuikue Ndam, N. G., Salanti, A., Le‐Hesran, J. ‐., Cottrell, G., Fievet, N., Turner, L., Sow, S., Dangou, J. ‐., Theander, T., & Deloron, P. (2006) · The Journal of Infectious Diseases · doi:10.1086/500146 · Cited by 89 · cited 2×
“A VAR2CSA vaccine will need to elicit a cross-reactive antibody response in order to be widely effective, and our data in conjunction with earlier studies [36,41,43] indicate DBL5e to be a promising vaccine candidate.”
BackgroundResultFc γ receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro
TEBO, A. E., KREMSNER, P. G., & LUTY, A. J. F. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01972.x · Cited by 84 · cited 1×
“adhesion to placental receptors [21] and to facilitate opsonic uptake by phagocytes [22,23,24].”
BackgroundStructural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA
Andersen, P., Nielsen, M. A., Resende, M., Rask, T. S., Dahlbäck, M., Theander, T., Lund, O., & Salanti, A. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040042 · Cited by 79 · cited 4×
“A recent study indicates that antibodies raised against DBL3x and DBL5e domains are highly cross-reactive with several placental isolates [39].”
BackgroundResultInfluentialBeeson, J. G., Amin, N., Kanjala, M., & Rogerson, S. J. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5412-5415.2002 · Cited by 78 · cited 1×
“Pregnancy-associated malaria (PAM) has a major impact on the mother and child [1] and is often associated with the sequestration of Plasmodium falciparum infected red blood cells (iRBC) in the placenta [2,3].”
BackgroundSelf-citationRasti, N., Namusoke, F., Chêne, A., Chen, Q., Staalsoe, T., Klinkert, M.-Q., Mirembe, F., Kironde, F., & Wahlgren, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601519103 · Cited by 69
Self-citationFeng, G., Aitken, E., Yosaatmadja, F., Kalilani, L., Meshnick, S. R., Jaworowski, A., Simpson, J. A., & Rogerson, S. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/599841 · Cited by 69 · cited 2×
“adhesion to placental receptors [21] and to facilitate opsonic uptake by phagocytes [22,23,24].”
BackgroundSelf-citationCreasey, A. M., Staalsoe, T., Raza, A., Arnot, D. E., & Rowe, J. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4767-4771.2003 · Cited by 67 · cited 3×
“Malaria naı̈ve sera showed binding only at background levels and as an extra control, we also used non-immune IgG and PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e9230 IgM as well as IgG depleted non-immune sera, neither exhibiting binding using the surface plasmon resonance technique (data not s…”
BackgroundTuikue Ndam, N. G., Fievet, N., Bertin, G., Cottrell, G., Gaye, A., & Deloron, P. (2004) · The Journal of Infectious Diseases · doi:10.1086/425521 · Cited by 67 · cited 1×
“Some studies found no association between high levels of VSA-PAM antibodies and adhesion inhibition [44], whereas some clearly show this”
BackgroundCharacterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies
Avril, M., Gamain, B., Lépolard, C., Viaud, N., Scherf, A., & Gysin, J. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.09.005 · Cited by 61 · cited 1×
“VAR2CSA contains six Duffy-binding-like (DBL) domains of which four (DBL2x, DBL3x, DBL5e and DBL6e) domains have been shown to bind CSA in vitro [14,15,16].”
BackgroundVAR2CSA Expression on the Surface of Placenta‐Derived Plasmodium falciparum–Infected Erythrocytes
Magistrado, P., Salanti, A., Tuikue Ndam, N. G., Mwakalinga, S. B., Resende, M., Dahlbäck, M., Hviid, L., Lusingu, J., Theander, T. G., & Nielsen, M. A. (2008) · The Journal of Infectious Diseases · doi:10.1086/591502 · Cited by 61 · cited 1×
“Levels of adhesion-inhibitory antibody correlated with levels of anti-DBL5e antibodies [41], and a recent study illustrated how antibodies raised against DBL3x and DBL5e were highly crossreactive with heterologous parasites [42].”
BackgroundOleinikov, A. V., Rossnagle, E., Francis, S., Mutabingwa, T. K., Fried, M., & Duffy, P. E. (2007) · The Journal of Infectious Diseases · doi:10.1086/518513 · Cited by 59 · cited 1×
“A study by Oleinikov et al showed that most antibodies elicited following immunization with DBL5e and DBL6e recognize polymorphic epitopes in the native protein [40].”
BackgroundBir, N., Yazdani, S. S., Avril, M., Layez, C., Gysin, J., & Chitnis, C. E. (2006) · Infection and Immunity · doi:10.1128/iai.00481-06 · Cited by 49 · cited 1×
“VAR2CSA contains six Duffy-binding-like (DBL) domains of which four (DBL2x, DBL3x, DBL5e and DBL6e) domains have been shown to bind CSA in vitro [14,15,16].”
BackgroundGamain, B., Smith, J. D., Avril, M., Baruch, D. I., Scherf, A., Gysin, J., & Miller, L. H. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04145.x · Cited by 40 · cited 1×
“shown to contain a 12-mer residue deletion and did not bind CSA [33].”
BackgroundNielsen, M. A., Resende, M., Alifrangis, M., Turner, L., Hviid, L., Theander, T. G., & Salanti, A. (2007) · Experimental Parasitology · doi:10.1016/j.exppara.2007.03.002 · Cited by 33 · cited 1×
“A recent study indicates that antibodies raised against DBL3x and DBL5e domains are highly cross-reactive with several placental isolates [39].”
BackgroundVAR2CSA Domains Expressed in Escherichia coli Induce Cross‐Reactive Antibodies to Native Protein
Oleinikov, A. V., Francis, S. E., Dorfman, J. R., Rossnagle, E., Balcaitis, S., Getz, T., Avril, M., Gose, S., Smith, J. D., Fried, M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/529526 · Cited by 31 · cited 1×
“A VAR2CSA vaccine will need to elicit a cross-reactive antibody response in order to be widely effective, and our data in conjunction with earlier studies [36,41,43] indicate DBL5e to be a promising vaccine candidate.”
ResultPlacental Pathologic Changes in Malaria: A Histologic and Ultrastructural Study
WALTER, P. R., GARIN, Y. J. F., & Blot, P. (1983) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198308000-00008 · Cited by 31
Research works printed but not linked: 1
- A Salanti, 2004, Evidence for the involvement of VAR2CSA in pregnancy-associated malaria., J Exp Med, 200, 1197, 10.1084/jem.20041579 · DOI · Paper page
Cited by
Fried, M., & Duffy, P. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025551 · Cited by 202
“…et al. 2007 Enrollmenta and delivery 2008–2010, Comé-Benin, perennial Ndam et al. 2015 No Third trimester 2000–2002, Blantyre-Malawi, perennial Brolin et al. 2010 Delivery 2003–2006, Manhica-Mozambique, perennial Mayor et al. 2013 DBL4 Yes Delivery 2008–2010, Comé-Benin,…”
InfluentialMordmüller, B., Sulyok, M., Egger-Adam, D., Resende, M., de Jongh, W. A., Jensen, M. H., Smedegaard, H. H., Ditlev, S. B., Soegaard, M., Poulsen, L., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1140 · Cited by 154
Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin
Ndam, N. T., Denoeud-Ndam, L., Doritchamou, J., Viwami, F., Salanti, A., Nielsen, M. A., Fievet, N., Massougbodji, A., Luty, A. J. F., & Deloron, P. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2105.141626 · Cited by 98
“Median fluorescence intensity was converted into relative fluorescence intensity as described (27).”
Designing a VAR2CSA-based vaccine to prevent placental malaria
Fried, M., & Duffy, P. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.011 · Cited by 86
Cutts, J. C., Agius, P. A., Lin, Z., Powell, R., Moore, K. A., Draper, B. L., Simpson, J. A., & Fowkes, F. J. I. (2020) · BMC Medicine · doi:10.1186/s12916-019-1467-6 · Cited by 102
Metadata
- Authors
- Brolin, K. J. M., Persson, K. E. M., Wahlgren, M., Rogerson, S. J., & Chen, Q.
- Affiliations
- Swedish Institute (SE)
- The Royal Melbourne Hospital (AU)
- Jilin University (CN)
- Corresponding author
- Rogerson, Stephen J.
- Chen, Qijun
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-16
- Volume
- 5
- Issue
- 2
- Pages
- e9230
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2821912
- OpenAlex
- W2068387678
- Cited by
- 24
- References
- 44
- Citations by year
- 2025: 1 · 2023: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 3 · 2015: 5 · 2014: 2 · 2013: 3 · 2012: 2
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Styrelsen för Internationellt Utvecklingssamarbete
- Wenner-Gren Stiftelserna
- Boehringer Ingelheim Fonds
- National Institutes of Health
- U.S. Public Health Service (A149084)
- Medical Research Council
- National Health and Medical Research Council
- National Key Research and Development Program of China (2007CB513100)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Keywords
- Plasmodium falciparum, VAR2CSA, malaria in pregnancy, placental sequestration, variant surface antigens, naturally acquired antibodies, HIV coinfection, antibody affinity, vaccine candidate, primigravida, pregnant women
- MeSH terms
- Adult, Animals, Antibodies, Antibody Affinity, Epitopes, Antigens, Protozoan, Binding Sites, Cricetulus, Female, Flow Cytometry, Cricetinae, Humans, Immunoglobulin G, Malawi, Pregnancy, Pregnancy Complications, Parasitic, HIV Infections, Comorbidity, CHO Cells, Malaria, Falciparum, Endemic Diseases, Gravidity, Surface Plasmon Resonance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.